Neutrophil Gelatinase-Associated Lipocalin (NGAL): an early marker for diabetic nephropathy

ISSN： 0973-3930

Source： International Journal of Diabetes in Developing Countries, Vol.32, Iss.1, 2012-03, pp. : 19-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neutrophil Gelatinase–Associated Lipocalin as an Early Marker of Contrast‐Induced Nephropathy After Elective Invasive Cardiac Procedures

Clinical Cardiology, Vol. 39, Iss. 8, 2016-08 ,pp. : 464-470

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Endothelial Progenitor Cells (EPCs) Evaluation in Aortic Aneurysm Repair

Current Vascular Pharmacology, Vol. 11, Iss. 6, 2013-11 ,pp. : 1001-1010

Bentham Science Publishers

Access to resources Recommend Favorite

Serum Neutrophil Gelatinase-Associated Lipocalin – A Sensitive Novel Marker of Renal Impairment in Liver Cirrhosis?

Digestion, Vol. 84, Iss. 1, 2011-04 ,pp. : 82-83

Karger

Access to resources Recommend Favorite

“Normoalbuminuric” diabetic nephropathy: tubular damage and NGAL

By Lacquaniti Antonio Donato Valentina Pintaudi Basilio Di Vieste Giacoma Chirico Valeria Buemi Antoine Di Benedetto Antonino Arena Adriana Buemi Michele

Acta Diabetologica, Vol. 50, Iss. 6, 2013-12 ,pp. : 935-942

Springer Publishing Company

Access to resources Recommend Favorite

Distinct Biomarkers for Early Diagnosis of Diabetic Nephropathy

Current Diabetes Reviews, Vol. 13, Iss. 6, 2017-10 ,pp. : 598-605

Bentham Science Publishers

Access to resources Recommend Favorite